1. Learning Objectives

  2. Describe the pathophysiology of CKD-MBD
  3. Assess bone health in chronic kidney disease
  4. Summarize the role of traditional anti-osteoporotic therapies in CKD-MBD
  5. Summarize treatment options for CKD-MBD


Session date: 
02/09/2018 - 8:00am to 9:00am CST
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Stuart Sprague, DO